Synthetic Biologics (SYN) Reports In-Line Q1 EPS

Synthetic Biologics (NYSE: SYN) reported Q1 EPS of ($0.03), in-line with the analyst estimate of ($0.03).

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance